- Home
- IXHL
as 07-26-2024 4:00pm EST
Stocks
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
| Founded: | 2001 | Country: | Australia |
| Employees: | N/A | City: | DOCKLANDS, VICTORIA |
| Market Cap: | 47.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 21.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.80 - $12.68 | Next Earning Date: | 08-15-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Incannex Healthcare Inc. News
IXHL Breaking Stock News: Dive into IXHL Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
GlobeNewswire
3 months ago
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
Newsfile
3 months ago
Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)
GlobeNewswire
3 months ago
Incannex Healthcare Inc. Quarterly Update, Q1 2024
GlobeNewswire
5 months ago
Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder
GlobeNewswire
5 months ago
Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation
GlobeNewswire
6 months ago
Clarion Clinics Open for Psychedelic-Assisted Treatments
PR Newswire
6 months ago
Vuzix Establishes Ophthalmic Advisory Board to Better Serve Human Vision Correction Needs with AR Glasses
Compare IXHL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IXHL Incannex Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.